The anti-tumor effect of trifluridine via induction of aberrant mitosis is unaffected by mutations modulating p53 activityCELL DEATH DISCOVERYIF72024-07-020OAAI
DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 StatusMOLECULAR CANCER RESEARCHIF4.72020-09-0210OAAI
The balance of forces generated by kinesins controls spindle polarity and chromosomal heterogeneity in tetraploid cellsJOURNAL OF CELL SCIENCEIF3.62019-12-139OAAI
Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression levelSCIENTIFIC REPORTSIF3.92019-05-2816OAAI
Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and CytotoxicityMOLECULAR CANCER RESEARCHIF4.72018-10-0212OAAI
TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based ChemotherapyMOLECULAR CANCER THERAPEUTICSIF5.52018-07-3126OAAI
TAS-114 is a novel dUTPase/DPD inhibitor, its DPD inhibition reduces capecitabine dosage but does not diminish therapeutic window in human tumor xenograftsEUROPEAN JOURNAL OF CANCERIF7.12014-11-010PREAI
TAS-114 Enhances S-1 Activity in Vivo When Used in CombinationEUROPEAN JOURNAL OF CANCERIF7.12012-11-013PREAI
TAS-114 in Combination, with Capecitabine-based Chemotherapy May Represent a Novel Therapeutic StrategyEUROPEAN JOURNAL OF CANCERIF7.12012-11-011PREAI
1,2,3-Triazole-Containing Uracil Derivatives with Excellent Pharmacokinetics as a Novel Class of Potent Human Deoxyuridine Triphosphatase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-07-0366PREAI
Discovery of Highly Potent Human Deoxyuridine Triphosphatase Inhibitors Based on the Conformation Restriction StrategyJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-05-3032PREAI
Synthesis and Discovery of N-Carbonylpyrrolidine- or N-Sulfonylpyrrolidine-Containing Uracil Derivatives as Potent Human Deoxyuridine Triphosphatase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-03-2620PREAI
Discovery of a Novel Class of Potent Human Deoxyuridine Triphosphatase Inhibitors Remarkably Enhancing the Antitumor Activity of Thymidylate Synthase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-03-2645PREAI